Does Omeprazole Decrease Intestinal Calcium Absorption?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00582972|
Recruitment Status : Completed
First Posted : December 28, 2007
Results First Posted : January 21, 2013
Last Update Posted : February 15, 2013
|Condition or disease||Intervention/treatment||Phase|
|Osteoporosis Achlorhydria GERD Hip Fracture||Drug: Omeprazole||Phase 4|
Existing literature makes it unclear whether proton pump inhibitor therapy truly decreases intestinal calcium absorption. Up to 25 postmenopausal women will participate in this study. The primary study outcome is the change in intestinal calcium absorption following omeprazole therapy 40 mg daily for 30 days. The secondary outcomes include the change in urine n-telopeptide.
We will interview women and review their medical records to determine eligibility. Eligible subjects will undergo three calcium absorption studies. The first 2 studies will determine the monthly variation in calcium absorption, while the 3rd study will occur after taking 40 mg of omeprazole daily for 30 days. Women will present to the research unit in the early morning and receive an oral and intravenous calcium tracer with breakfast. Over the next 24 hours, we will collect all urine for measurement of its calcium content. During the first stay, we will measure each subject's gastric pH by collecting gastric fluid from a temporary nasogastric tube. In consenting subjects we will collect one tube of blood, isolate its DNA.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||23 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Does Omeprazole Decrease Intestinal Calcium Absorption?|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||December 2008|
|Actual Study Completion Date :||December 2010|
Subjects will receive omeprazole 40 mg daily for 30 days
40 mg po qAM one-half hour before breakfast for 30 days
- Change in Intestinal Calcium Absorption From Baseline to One Month [ Time Frame: change in calcium absorption from baseline to 1 month ]percent calcium absorption
- Change in Bone Resorption From Baseline to 1 Month [ Time Frame: change in bone resorption from baseline to 1 month ]urine n-telopeptide (normalized to creatinine levels)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00582972
|United States, Wisconsin|
|University of Wisconsin Hospital and Clinics|
|Madison, Wisconsin, United States, 53792|
|Principal Investigator:||Karen E Hansen, MD||Univeristy of Wisconsin School of Medicine and Public Health|